Literature DB >> 3529080

Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene.

J Brennand, G P Margison.   

Abstract

The toxic, mutagenic, and carcinogenic effects of alkylating agents have been attributed to their ability to damage DNA. Reaction at the O6 position of guanine results in miscoding during DNA replication, has been shown to be mutagenic in both bacteriophage and bacteria, and may be responsible for malignant transformation. In common with many other prokaryotes and eukaryotes the Escherichia coli B strain contains a protein that repairs O6-alkylation damage in DNA by transferring the alkyl group to one of its own cysteine residues. We have recently cloned the E. coli O6-alkylguanine alkyltransferase gene and shown it to encode a 37-kDa protein containing an additional activity that removes alkyl groups from alkylphosphotriesters in DNA. To examine the biological effects of this gene in mammalian cells, we have now inserted the coding sequence into a retrovirus-based selectable expression vector and transfected it into Chinese hamster V79 cells that lack endogenous alkyltransferase activity. A clone expressing high levels of the bacterial protein was selected and shown to produce a 37-kDa alkyltransferase protein and to rapidly repair O6-methylguanine produced in the host genome following exposure to N-methyl-N-nitrosourea. In comparison with a control population, this clone is considerably more resistant to the toxic and mutagenic effects of alkylating agents that react extensively with oxygen atoms in DNA. The usefulness of these clones in examining the role of DNA alkylation and other biological effects of alkylating agents is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3529080      PMCID: PMC386489          DOI: 10.1073/pnas.83.17.6292

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Induction and autoregulation of ada, a positively acting element regulating the response of Escherichia coli K-12 to methylating agents.

Authors:  P K Lemotte; G C Walker
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

2.  Purification and structure of the intact Ada regulatory protein of Escherichia coli K12, O6-methylguanine-DNA methyltransferase.

Authors:  Y Nakabeppu; H Kondo; S Kawabata; S Iwanaga; M Sekiguchi
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

Review 3.  Mechanisms of carcinogenesis induced by alkylating agents.

Authors:  R Saffhill; G P Margison; P J O'Connor
Journal:  Biochim Biophys Acta       Date:  1985-12-17

4.  Expression of the E. coli O6-methylguanine-methylphosphotriester methyltransferase gene in mammalian cells.

Authors:  J Brennand; G P Margison
Journal:  Carcinogenesis       Date:  1986-01       Impact factor: 4.944

5.  Exposure of HeLa cells to 0(6)-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents.

Authors:  M E Dolan; C D Corsico; A E Pegg
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

6.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.

Authors:  H Zarbl; S Sukumar; A V Arthur; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

7.  Cloning of the E. coli O6-methylguanine and methylphosphotriester methyltransferase gene using a functional DNA repair assay.

Authors:  G P Margison; D P Cooper; J Brennand
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

8.  Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis.

Authors:  B Demple; B Sedgwick; P Robins; N Totty; M D Waterfield; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Factors governing the expression of a bacterial gene in mammalian cells.

Authors:  R C Mulligan; P Berg
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

10.  Induction of resistance to alkylating agents in E. coli: the ada+ gene product serves both as a regulatory protein and as an enzyme for repair of mutagenic damage.

Authors:  I Teo; B Sedgwick; B Demple; B Li; T Lindahl
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  37 in total

1.  Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N'-nitro-N-nitrosoguanidine-induced mutation, transformation, and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes.

Authors:  E von Hofe; L Fairbairn; G P Margison
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  How heterologously expressed Escherichia coli genes contribute to understanding DNA repair processes in Saccharomyces cerevisiae.

Authors:  Jela Brozmanová; Viera Vlcková; Miroslav Chovanec
Journal:  Curr Genet       Date:  2004-11-13       Impact factor: 3.886

3.  The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.

Authors:  Abdel Nasser Hosein; Yi Chieh Lim; Bryan Day; Brett Stringer; Stephen Rose; Richard Head; Leah Cosgrove; Peter Sminia; Michael Fay; Jennifer H Martin
Journal:  J Neurooncol       Date:  2015-02-04       Impact factor: 4.130

Review 4.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 5.  Biocatalysis made to order.

Authors:  G Tripathi
Journal:  Appl Biochem Biotechnol       Date:  1988-10       Impact factor: 2.926

6.  Transfer of human genes conferring resistance to methylating mutagens, but not to UV irradiation and cross-linking agents, into Chinese hamster ovary cells.

Authors:  B Kaina; A A Van Zeeland; C Backendorf; H W Thielmann; P Van de Putte
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

7.  Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.

Authors:  C Dive; P Workman; J V Watson
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Systems based mapping demonstrates that recovery from alkylation damage requires DNA repair, RNA processing, and translation associated networks.

Authors:  John P Rooney; Ajish D George; Ashish Patil; Ulrike Begley; Erin Bessette; Maria R Zappala; Xin Huang; Douglas S Conklin; Richard P Cunningham; Thomas J Begley
Journal:  Genomics       Date:  2008-10-16       Impact factor: 5.736

9.  Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.

Authors:  K A van Nifterik; J van den Berg; W F van der Meide; N Ameziane; L E Wedekind; R D M Steenbergen; S Leenstra; M V M Lafleur; B J Slotman; L J A Stalpers; P Sminia
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

10.  O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.

Authors:  A J Watson; M R Middleton; G McGown; M Thorncroft; M Ranson; P Hersey; G McArthur; I D Davis; D Thomson; J Beith; A Haydon; R Kefford; P Lorigan; P Mortimer; A Sabharwal; O Hayward; G P Margison
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.